In addition to bladder cancer, previous studies have shown that targeting CD47 and angiogenesis is also effective in inhibiting the growth of gastric cancer, glioblastoma, and non-small cell lung cancer by mediating similar mechanisms. Here, CD47 is linked to urinary bladder cancer.